Thomas K. Equels - Net Worth and Insider Trading
Thomas K. Equels Net Worth
The estimated net worth of Thomas K. Equels is at least $341,677 dollars as of 2024-04-19. Thomas K. Equels is the CEO & President of AIM ImmunoTech Inc and owns about 716,455 shares of AIM ImmunoTech Inc (AIM) stock worth over $341,677. Details can be seen in Thomas K. Equels's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas K. Equels has not made any transactions after 2024-03-15 and currently still holds the listed stock(s).
Transaction Summary of Thomas K. Equels
Thomas K. Equels Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas K. Equels owns 1 companies in total, including AIM ImmunoTech Inc (AIM) .
Click here to see the complete history of Thomas K. Equels’s form 4 insider trades.
Insider Ownership Summary of Thomas K. Equels
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AIM | AIM ImmunoTech Inc | 2024-03-15 | director & Vice Chairman of Board |
Thomas K. Equels Latest Holdings Summary
Thomas K. Equels currently owns a total of 1 stock. Thomas K. Equels owns 716,455 shares of AIM ImmunoTech Inc (AIM) as of March 15, 2024, with a value of $341,677.
Latest Holdings of Thomas K. Equels
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AIM | AIM ImmunoTech Inc | 2024-03-15 | 716,455 | 0.48 | 341,677 |
Holding Weightings of Thomas K. Equels
Thomas K. Equels Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas K. Equels has made a total of 15 transactions in AIM ImmunoTech Inc (AIM) over the past 5 years, including 15 buys and 0 sells. The most-recent trade in AIM ImmunoTech Inc is the acquisition of 75,758 shares on March 15, 2024, which cost Thomas K. Equels around $25,000.
Insider Trading History of Thomas K. Equels
- 1
Thomas K. Equels Trading Performance
GuruFocus tracks the stock performance after each of Thomas K. Equels's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas K. Equels is -18.65%. GuruFocus also compares Thomas K. Equels's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas K. Equels within 3 months outperforms 4 times out of 25 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Thomas K. Equels's insider trading performs compared to the benchmark.
Performance of Thomas K. Equels
Average Return
-50.99%
Outperforming Transactions
10%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.23 | -18.65 | -28.89 | -50.99 | -46.53 | -47.29 |
| Relative Return to S&P 500(%) | 0.71 | -22.12 | -37.94 | -62.7 | -56.98 | -59.65 |
Thomas K. Equels Ownership Network
Ownership Network List of Thomas K. Equels
Ownership Network Relation of Thomas K. Equels
Thomas K. Equels Owned Company Details
What does AIM ImmunoTech Inc do?
Who are the key executives at AIM ImmunoTech Inc?
Thomas K. Equels is the director & Vice Chairman of Board of AIM ImmunoTech Inc. Other key executives at AIM ImmunoTech Inc include CFO Ellen M Lintal , other: Medical Director David R Strayer , and VP of Operations Wayne S. Springate .
AIM ImmunoTech Inc (AIM) Insider Trades Summary
Over the past 18 months, Thomas K. Equels made 7 insider transaction in AIM ImmunoTech Inc (AIM) with a net purchase of 333,751. Other recent insider transactions involving AIM ImmunoTech Inc (AIM) include a net purchase of 171,556 shares made by Stewart Appelrouth , a net purchase of 118,525 shares made by Rodino Peter W. Iii , and a net purchase of 38,462 shares made by Nancy Bryan .
In summary, during the past 3 months, insiders sold 0 shares of AIM ImmunoTech Inc (AIM) in total and bought 243,009 shares, with a net purchase of 243,009 shares. During the past 18 months, 0 shares of AIM ImmunoTech Inc (AIM) were sold and 662,294 shares were bought by its insiders, resulting in a net purchase of 662,294 shares.
AIM ImmunoTech Inc (AIM)'s detailed insider trading history can be found in Insider Trading Tracker table.
AIM ImmunoTech Inc Insider Transactions
Thomas K. Equels Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas K. Equels. You might contact Thomas K. Equels via mailing address: 2117 Southwest Highway 484, Ocala Fl 34473.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
